These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 20561470

  • 1. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 3. Bisphosponates and dental implants: a case report and a brief review of literature.
    Ferlito S, Liardo C, Puzzo S.
    Minerva Stomatol; 2011 Feb; 60(1-2):75-81. PubMed ID: 21252851
    [Abstract] [Full Text] [Related]

  • 4. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 5. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL.
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P, Nammour S.
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA, Schubert MM, Peterson DE, Seneda LM.
    Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121
    [Abstract] [Full Text] [Related]

  • 10. Dental endosseous implants in patients on bisphosphonate therapy.
    Scully C, Madrid C, Bagan J.
    Implant Dent; 2006 Sep 01; 15(3):212-8. PubMed ID: 16966893
    [Abstract] [Full Text] [Related]

  • 11. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 12. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep 01; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 13. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT, Chiang WF, Chuang CY, Chang SW.
    J Oral Maxillofac Surg; 2010 May 01; 68(5):1055-63. PubMed ID: 20403529
    [Abstract] [Full Text] [Related]

  • 14. Mandibular bisphosphonate-related osteonecrosis after dental implant rehabilitation: a case report.
    Sverzut CE, Sverzut AT, de Matos FP, Kato RB, Trivellato AE, de Oliveira PT.
    Implant Dent; 2012 Dec 01; 21(6):449-53. PubMed ID: 23075811
    [Abstract] [Full Text] [Related]

  • 15. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
    Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A.
    J Periodontol; 2007 Sep 01; 78(9):1664-9. PubMed ID: 17760533
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 17. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
    Madrid C, Sanz M.
    Clin Oral Implants Res; 2009 Sep 01; 20 Suppl 4():87-95. PubMed ID: 19663954
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
    Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N.
    J Oral Maxillofac Surg; 2010 Apr 01; 68(4):790-6. PubMed ID: 20307764
    [Abstract] [Full Text] [Related]

  • 19. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N.
    J Comput Assist Tomogr; 2009 Apr 01; 33(2):298-304. PubMed ID: 19346864
    [Abstract] [Full Text] [Related]

  • 20. Unusual case of a conservatively treated pathological fracture after sequestrectomy in a patient with long-term oral bisphosphonate use.
    Kuijpers SC, van Roessel EW, van Merkesteyn JP.
    J Craniomaxillofac Surg; 2011 Jan 01; 39(1):69-72. PubMed ID: 20435482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.